계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
MGB Biopharma
About
MGB Biopharma develops DNA minor groove binders-based anti-infective medicines.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- £1.30M
- Industries
- Biotechnology,Health Care,Medical Device
- Founded date
- Jan 1, 2009
- Number Of Employee
- 1 - 10
- Operating Status
- Active
MGB Biopharma Limited is a biopharmaceutical company established to develop a completely new class of anti-infective medicines based upon compounds which are DNA Minor Groove Binders (MGB)The company has an exceptionally experienced team from both pharma and biotech sectors and is dedicating its focus initially to the development of small molecules with specific antibacterial efffects against resistant bacteriaBy selecting a new class of antibacterial, the company believes the novel mode of action should prove to be very potent against bacteria as these target organisms will lack any inherent resistance, unlike that typically facing new drugs which are the result of modifications from existing classes of drugs used to treat bacterial infection
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 30, 2019 | Series Unknown | — | 1 | — | — | Detail |
| Sep 14, 2018 | Series Unknown | £1.30M | 1 | — | — | Detail |
| Apr 6, 2017 | Series Unknown | £0.92M | 1 | — | — | Detail |
| Sep 17, 2014 | Series B | $6.40M | 1 | — | — | Detail |
| Mar 31, 2010 | Series A | $3.03M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Barwell Plc
|
— | Series Unknown |
